Active, not recruitingPhase 1NCT06738017

Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
BioMarin Pharmaceutical
Principal Investigator
Medical Director, MD
BioMarin Pharmaceutical
Intervention
BMN 349(drug)
Enrollment
6 enrolled
Eligibility
18-75 years · All sexes
Timeline
20252025

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06738017 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency

← Back to all trials